Cargando…

In vivo evolution to echinocandin resistance and increasing clonal heterogeneity in Candida auris during a difficult-to-control hospital outbreak, Italy, 2019 to 2022

A difficult-to-control outbreak of Candida auris is ongoing in a large tertiary care hospital in Liguria, Italy, where it first emerged in 2019. In a retrospective analysis, 503 cases of C. auris carriage or infection were observed between July 2019 and December 2022. Genomic surveillance identified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Codda, Giulia, Willison, Edward, Magnasco, Laura, Morici, Paola, Giacobbe, Daniele Roberto, Mencacci, Antonella, Marini, Daniele, Mikulska, Malgorzata, Bassetti, Matteo, Marchese, Anna, Di Pilato, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283462/ https://www.ncbi.nlm.nih.gov/pubmed/37022211 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.14.2300161

Ejemplares similares

Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

Molecular Epidemiological Investigation of a Nosocomial Cluster of C. auris: Evidence of Recent Emergence in Italy and Ease of Transmission during the COVID-19 Pandemic
por: Di Pilato, Vincenzo, et al.
Publicado: (2021)

Isolation of Candida auris from invasive and non-invasive samples of a patient suffering from vascular disease, Italy, July 2019
por: Crea, Francesca, et al.
Publicado: (2019)

Spread of Carbapenem-Resistant Gram-Negatives and Candida auris during the COVID-19 Pandemic in Critically Ill Patients: One Step Back in Antimicrobial Stewardship?
por: Magnasco, Laura, et al.
Publicado: (2021)

Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
por: Briano, Federica, et al.
Publicado: (2022)

Echinocandins as Biotechnological Tools for Treating Candida auris Infections
por: Cândido, Elizabete de Souza, et al.
Publicado: (2020)

In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris
por: Caballero, Unai, et al.
Publicado: (2021)

In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris
por: Badalii, Hamid
Publicado: (2017)

Transcriptomics and Phenotyping Define Genetic Signatures Associated with Echinocandin Resistance in Candida auris
por: Jenull, Sabrina, et al.
Publicado: (2022)

Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit
por: Mikulska, Malgorzata, et al.
Publicado: (2022)

New Clonal Strain of Candida auris, Delhi, India: New Clonal Strain of Candida auris, Delhi, India
por: Chowdhary, Anuradha, et al.
Publicado: (2013)

Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019
por: Stathi, Angeliki, et al.
Publicado: (2019)

Increasing number of cases and outbreaks caused by Candida auris in the EU/EEA, 2020 to 2021
por: Kohlenberg, Anke, et al.
Publicado: (2022)

Candida auris Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS
por: Vatanshenassan, Mansoureh, et al.
Publicado: (2019)

Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance
por: Kordalewska, Milena, et al.
Publicado: (2023)

PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris
por: Caballero, Unai, et al.
Publicado: (2023)

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018)

Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria
por: Biagi, Mark J, et al.
Publicado: (2019)

Transmission of Pan-resistant and Echinocandin-resistant Candida Auris Between Healthcare Facilities During the COVID-19 Pandemic
por: Dang, Thi, et al.
Publicado: (2022)

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2022)

Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model
por: Hager, Christopher L, et al.
Publicado: (2018)

Candida auris‒Associated Hospitalizations, United States, 2017–2022
por: Benedict, Kaitlin, et al.
Publicado: (2023)

The global challenge of Candida auris in the intensive care unit
por: Cortegiani, Andrea, et al.
Publicado: (2019)

Evaluation of the Efficacy of CD101, a Novel Echinocandin, in the Treatment of Candida auris Infection Using a Murine Model of Disseminated Candidiasis
por: Hager, Christopher, et al.
Publicado: (2017)

733. Ibrexafungerp Demonstrates Potent and Consistent In Vitro Activity Against >400 Global Candida auris Isolates, Including isolates with Elevated MIC’s to Echinocandins
por: Borroto-Esoda, Katyna, et al.
Publicado: (2020)

1445. Public Health Containment Response Detects Possible Transmission of Echinocandin-Resistant Candida auris in a Long-term Acute Care Hospital
por: Brennan, Brenda M, et al.
Publicado: (2023)

Echinocandin-resistant Candida tropicalis Bloodstream Infections
por: Sfeir, Maroun, et al.
Publicado: (2017)

Is Candida auris sexual?
por: Ross, Zoe K., et al.
Publicado: (2020)

Candida auris is Coming
por: Hegde, Ashit
Publicado: (2022)

P017 Echinocandin resistance mechanism in Candida tropicalis and Candida glabrata
por: Sharma, Dipti, et al.
Publicado: (2022)

Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021
por: Lyman, Meghan, et al.
Publicado: (2021)

Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
por: Healey, Kelley R., et al.
Publicado: (2018)

First Case of Echinocandin-Resistant Candida albicans in Korea
por: Park, Min-Seung, et al.
Publicado: (2017)

Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland
por: Coste, A. T., et al.
Publicado: (2020)

NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
por: Cleare, Levi G., et al.
Publicado: (2020)

Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?
por: Vena, Antonio, et al.
Publicado: (2022)

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China
por: Ning, Yating, et al.
Publicado: (2022)

Candida auris in the Age of Resistance
por: Oh, Michael, et al.
Publicado: (2020)

Candida auris in Dog Ears
por: Yadav, Anamika, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ersn3l2ft9pefl5ksak9tpni60